中国临床药理学杂志2011，Vol.27Issue(8)：654-656,3.
我国药物临床试验机构伦理委员会的现状及监管对策
Current status and regulatory measures for the ethics committee of drug clinical trial institutions in China
沈玉红 1张正付 1李正奇1
作者信息
- 1. 国家食品药品监督管理局药品认证管理中心,北京,100061
- 折叠
摘要
Abstract
The construction for the ethics committee is still being standardized in China. This paper explored the regulatory measures for the ethics committee of drug clinical trial institutions according to the current status and problems faced by the ethics committee of drug clinical trial institutions in China, and the aim was to gradually regulate the construction and development.关键词
药物临床试验/现状/监管对策Key words
drug clinical trial/current status/regulatory measures分类
医药卫生引用本文复制引用
沈玉红,张正付,李正奇..我国药物临床试验机构伦理委员会的现状及监管对策[J].中国临床药理学杂志,2011,27(8):654-656,3.
